What prices were received in Mark Hancock’s PACS (PACS) share sales?

The reported weighted average prices were $40.3255, $40.4964, and $41.0100 per share. Footnotes note these are averages for multiple trades, with actual prices ranging from $40.00 to about $41.0016 per PACS Group common share.

Were Mark Hancock’s PACS (PACS) share sales under a Rule 10b5-1 plan?

Yes. A footnote states the sale reported in this Form 4 was effected under a Rule 10b5-1 trading plan adopted on March 11, 2026. Such plans schedule trades in advance, reducing the significance of short-term market timing.

PACS Group (PACS) co-founder Mark Hancock sells 200,000 shares

Q: How many PACS (PACS) shares did Mark Hancock sell in this Form 4?

Mark Hancock reported selling a total of 200,000 shares of PACS Group common stock. The transactions were split across three sales on June 25 and 26, 2026, at weighted average prices around $40–$41 per share.

Q: How many PACS (PACS) shares does Mark Hancock hold after these transactions?

After the reported sales, Mark Hancock directly holds 54,102,597 shares of PACS Group common stock. This figure, disclosed in the filing’s post-transaction ownership columns, shows he retains a very large ongoing equity position in the company.

Q: Were Mark Hancock’s PACS (PACS) sales open-market transactions?

Yes. Each transaction is coded “S” and described as a sale in open market or private transaction , with the filing specifying open-market sale. The shares involved were PACS Group common stock held directly by Hancock, not derivative securities.

Q: How many PACS (PACS) sell transactions does this Form 4 report?

The Form 4 lists three separate non-derivative sale transactions in PACS Group common stock. Two occurred on June 26, 2026 and one on June 25, 2026, together totaling 200,000 shares sold according to the transaction summary data.

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

PACS Group, Inc. director and executive vice chair Mark Hancock reported open-market sales of a total of 200,000 shares of common stock. The trades occurred on June 25 and 26, 2026 at weighted average prices around $40–$41 per share.

The filing shows Hancock continues to hold more than 54 million shares of PACS Group common stock directly after these transactions. According to a footnote, the June 2026 sales were effected under a pre‑arranged Rule 10b5-1 trading plan adopted on March 11, 2026, indicating they were scheduled in advance rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 200,000 shares ($8,075,787)

Net Sell 3 txns

Insider Hancock Mark

Role Co Fndr; Exec V Chair

Sold 200,000 shs ($8.08M)

Type	Security	Shares	Price	Value
Sale	Common Stock	61,731	$40.4964	$2.50M
Sale	Common Stock	200	$41.01	$8K
Sale	Common Stock	138,069	$40.3255	$5.57M

Holdings After Transaction: Common Stock — 54,102,797 shares (Direct, null)

Footnotes (1)

The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $40.00 to $40.67 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $40.01 to $41.0016 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 200,000 shares Sale price 1: $40.3255 per share Sale price 2: $40.4964 per share +5 more

8 metrics

Shares sold 200,000 shares Total common stock sold across three transactions

Sale price 1 $40.3255 per share Weighted average price on June 25, 2026 sale

Sale price 2 $40.4964 per share Weighted average price on one June 26, 2026 sale

Sale price 3 $41.0100 per share Weighted average price on second June 26, 2026 sale

Post-transaction holdings 54,102,597 shares Common stock held directly after June 26, 2026 trades

Trading plan adoption date March 11, 2026 Rule 10b5-1 plan governing the reported sale

Reported price range (footnote F2) $40.00–$40.67 per share Actual trade range underlying one weighted average

Reported price range (footnote F3) $40.01–$41.0016 per share Actual trade range underlying another weighted average

Key Terms

Rule 10b5-1 trading plan, weighted average price, open-market sale, Form 4

4 terms

Rule 10b5-1 trading plan regulatory

"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 regulatory

"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/26/2026 - 06:12 PM Accepted by SEC EDGAR 06/26/2026 - 06:12 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hancock Mark

(Last)

(First)

(Middle)

C/O PACS GROUP, INC.

90 S. 400 W. SUITE 700

(Street)

SALT LAKE CITY

UTAH

84101

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Co Fndr; Exec V Chair

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/25/2026		S⁽¹⁾		138,069	D	$40.3255⁽²⁾	54,164,528	D
Common Stock	06/26/2026		S⁽¹⁾		61,731	D	$40.4964⁽³⁾	54,102,797	D
Common Stock	06/26/2026		S⁽¹⁾		200	D	$41.01	54,102,597	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026.

2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $40.00 to $40.67 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $40.01 to $41.0016 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ John Mitchell, Attorney-in-Fact	06/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

How many PACS (PACS) shares did Mark Hancock sell in this Form 4?

Mark Hancock reported selling a total of 200,000 shares of PACS Group common stock. The transactions were split across three sales on June 25 and 26, 2026, at weighted average prices around $40–$41 per share.

How many PACS (PACS) shares does Mark Hancock hold after these transactions?

After the reported sales, Mark Hancock directly holds 54,102,597 shares of PACS Group common stock. This figure, disclosed in the filing’s post-transaction ownership columns, shows he retains a very large ongoing equity position in the company.

Were Mark Hancock’s PACS (PACS) sales open-market transactions?

Yes. Each transaction is coded “S” and described as a sale in open market or private transaction, with the filing specifying open-market sale. The shares involved were PACS Group common stock held directly by Hancock, not derivative securities.

How many PACS (PACS) sell transactions does this Form 4 report?

The Form 4 lists three separate non-derivative sale transactions in PACS Group common stock. Two occurred on June 26, 2026 and one on June 25, 2026, together totaling 200,000 shares sold according to the transaction summary data.